Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Genzyme Transgenics

This article was originally published in The Tan Sheet

Executive Summary

Genzyme Transgenics: Plans to develop a nutritional supplement or "nutraceutical" containing prolactin, "a protein normally produced by the body" with a "broad effect on the immune system," according to SBC Warburg Dillon Read analysts Mary Ann Gray, PhD, and Susan Burnett. Genzyme has produced the protein in the milk of transgenic animals. "Prolactin is also present in human milk and is thought to aid in the maturation of the immune systems in nursing infants," the analysts add. Nutritional supplements "face fewer hurdles and a shorter development timeline than traditional pharmaceuticals," they note...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel